This Is Where Our Future Is Bright

We began the journey to establish our chronic kidney care and acute therapies businesses into one standalone company in January 2023. The proposed separation from Baxter will establish a new company with an impressive 70 years of experience and a single focus on advancing therapies and services for kidney care and other vital organ support.

Perhaps you are considering a career with Baxter and are wondering how these changes will impact you. Or maybe you are curious what professional opportunities the new company will offer. There are many exciting changes on the horizon, and we are grateful for your interest.

Learn more about how change creates opportunity at Baxter here.